Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Report

Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Workflow, By Technology (WGS, WES), By Application (Screening, Companion Diagnostics), By End-use, And Segment Forecasts, 2021 - 2028

  • Report ID: GVR-3-68038-791-9
  • Number of Pages: 155
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2019
  • Industry: Healthcare

Market Segmentation

  • Clinical Oncology NGS Technology Outlook (Revenue, USD Million, 2017 - 2028)
    • Whole Genome Sequencing
    • Whole Exome Sequencing
    • Targeted Sequencing & Resequencing
  • Clinical Oncology NGS Workflow Outlook (Revenue, USD Million, 2017 - 2028)
    • NGS Pre-Sequencing
    • NGS Sequencing
    • NGS Data Analysis
  • Clinical Oncology NGS Application Outlook (Revenue, USD Million, 2017 - 2028)
    • Screening
    • Sporadic Cancer
    • Inherited Cancer
    • Companion Diagnostics
    • Others
  • Clinical Oncology NGS End Use Outlook (Revenue, USD Million, 2017 - 2028)
    • Hospitals
    • Clinics
    • Laboratories
  • Clinical Oncology NGS Regional Outlook (Revenue, USD Million, 2017 - 2028)
    • North America
      • North America Clinical Oncology NGS Market, By Technology
        • Whole Genome Sequencing
        • Whole Exome Sequencing
        • Targeted Sequencing & Resequencing
      • North America Clinical Oncology NGS Market, By Workflow
        • NGS Pre-Sequencing
        • NGS Sequencing
        • NGS Data Analysis
      • North America Clinical Oncology NGS, By Application
        • Screening
          • Sporadic Cancer
          • Inherited Cancer
        • Companion Diagnostics
        • Others
      • North America Clinical Oncology NGS Market, By End Use
        • Hospitals
        • Clinics
        • Laboratories
      • U.S.
        • U.S. Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • U.S. Clinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • U.S. Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • U.S. Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories
      • Canada
        • Canada Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • Canada Clinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • Canada Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • Canada Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories
    • Europe
      • Europe Clinical Oncology NGS Market, By Technology
        • Whole Genome Sequencing
        • Whole Exome Sequencing
        • Targeted Sequencing & Resequencing
      • Europe Clinical Oncology NGS Market, By Workflow
        • NGS Pre-Sequencing
        • NGS Sequencing
        • NGS Data Analysis
      • Europe Clinical Oncology NGS, By Application
        • Screening
          • Sporadic Cancer
          • Inherited Cancer
        • Companion Diagnostics
        • Others
      • Europe Clinical Oncology NGS Market, By End Use
        • Hospitals
        • Clinics
        • Laboratories
      • Germany
        • Germany Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • Germany Clinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • Germany Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • Germany Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories
      • U.K.
        • U.K Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • U.K Clinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • U.K Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • U.K Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories
      • France
        • France Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • France Clinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • France Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • France Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories
      • Italy
        • Italy Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • Italy Clinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • Italy Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • Italy Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories
      • Spain
        • Spain Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • Spain Clinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • Spain Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • Spain Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories
    • Asia Pacific
      • Asia Pacific Clinical Oncology NGS Market, By Technology
        • Whole Genome Sequencing
        • Whole Exome Sequencing
        • Targeted Sequencing & Resequencing
      • Asia Pacific Clinical Oncology NGS Market, By Workflow
        • NGS Pre-Sequencing
        • NGS Sequencing
        • NGS Data Analysis
      • Asia Pacific Clinical Oncology NGS, By Application
        • Screening
          • Sporadic Cancer
          • Inherited Cancer
        • Companion Diagnostics
        • Others
      • Asia Pacific Clinical Oncology NGS Market, By End Use
        • Hospitals
        • Clinics
        • Laboratories
      • Japan
        • Japan Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • Japan Clinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • Japan Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • Japan Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories
      • China
        • China Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • China Clinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • China Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • China Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories
      • India
        • India Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • India Clinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • India Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • India Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories
      • South Korea
        • South Korea Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • South Korea Clinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • South Korea Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • South Korea Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories
      • Australia
        • Australia Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • AustraliaClinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • Australia Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • Australia Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories
    • Latin America
      • Latin America Clinical Oncology NGS Market, By Technology
        • Whole Genome Sequencing
        • Whole Exome Sequencing
        • Targeted Sequencing & Resequencing
      • Latin America Clinical Oncology NGS Market, By Workflow
        • NGS Pre-Sequencing
        • NGS Sequencing
        • NGS Data Analysis
      • Latin America Clinical Oncology NGS, By Application
        • Screening
          • Sporadic Cancer
          • Inherited Cancer
        • Companion Diagnostics
        • Others
      • Latin America Clinical Oncology NGS Market, By End Use
        • Hospitals
        • Clinics
        • Laboratories
      • Brazil
        • Brazil Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • Brazil Clinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • Brazil Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • Brazil Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories
      • Mexico
        • Mexico Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • Mexico Clinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • Mexico Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • Mexico Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories
    • Middle East and Africa (MEA)
      • Middle East and Africa Clinical Oncology NGS Market, By Technology
        • Whole Genome Sequencing
        • Whole Exome Sequencing
        • Targeted Sequencing & Resequencing
      • Middle East and AfricaClinical Oncology NGS Market, By Workflow
        • NGS Pre-Sequencing
        • NGS Sequencing
        • NGS Data Analysis
      • Middle East and Africa Clinical Oncology NGS, By Application
        • Screening
          • Sporadic Cancer
          • Inherited Cancer
        • Companion Diagnostics
        • Others
      • Middle East and Africa Clinical Oncology NGS Market, By End Use
        • Hospitals
        • Clinics
        • Laboratories
      • South Africa
        • South Africa Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • South Africa Clinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • South Africa Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • South Africa Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories
      • Saudi Arabia
        • Saudi Arabia Clinical Oncology NGS Market, By Technology
          • Whole Genome Sequencing
          • Whole Exome Sequencing
          • Targeted Sequencing & Resequencing
        • Saudi Arabia Clinical Oncology NGS Market, By Workflow
          • NGS Pre-Sequencing
          • NGS Sequencing
          • NGS Data Analysis
        • Saudi Arabia Clinical Oncology NGS, By Application
          • Screening
            • Sporadic Cancer
            • Inherited Cancer
          • Companion Diagnostics
          • Others
        • Saudi Arabia Clinical Oncology NGS Market, By End Use
          • Hospitals
          • Clinics
          • Laboratories

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2017 to 2028
  • Market estimates and forecast for product segments up to 2028
  • Regional market size and forecast for product segments up to 2028
  • Market estimates and forecast for application segments up to 2028
  • Regional market size and forecast for application segments up to 2028
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.